Furthermore, ATRA [X] treatment restores brain-derived neurotrophic factor (BDNF) dependence of neuroblastoma cells, and a BDNF-dependent increase in amyloid precursor protein (APP) gene expression was also observed (33). The gene discussed is APP; the disease is neuroblastoma.